Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MRS Measurement of Glutamate and GABA Metabolism in Brain

NCT: NCT00109174 · RECRUITING

NCT IDNCT00109174
StatusRECRUITING
Start Date2006-09-06
Completion2030-03-11

Brief Summary

This study will use magnetic resonance spectroscopy (MRS) to measure in the brain the transfer of \[13\]C as it is naturally metabolized from glucose to specific chemical transmitters. From this method, we can measure the rate of production of an important excitatory neurotransmitter (glutamate) as well as an inhibitory neurotransmitter (GABA).

Frequently Asked Questions

What is MRS Measurement of Glutamate and GABA Metabolism in Brain?

MRS Measurement of Glutamate and GABA Metabolism in Brain is a clinical trial registered under NCT00109174. Current status: RECRUITING.

What is the status of NCT00109174?

The current status of NCT00109174 (MRS Measurement of Glutamate and GABA Metabolism in Brain) is: RECRUITING.

When did MRS Measurement of Glutamate and GABA Metabolism in Brain start?

MRS Measurement of Glutamate and GABA Metabolism in Brain started on 2006-09-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.